Medicines Management
Clinical Policies
Recent changes for Medicines Management
Drugs
Leuprorelin
Sirolimus
Triptorelin
Dabrafenib
Goserelin
Pembrolizumab
Remdesivir (Veklury)
Trastuzumab deruxtecan
Selinexor
Setmelanotide
Tixagevimab + cilgavimab
Zanubrutinib
Atogepant
Cytisinicline (Cytisine)
Buserelin
Gonadorelin
Nafarelin
General Information
High Cost Drugs exc. from tariff
Controlled Drugs
BNF Chapters
BNF 6 Endocrine
JAPC Bulletins
Bulletin May 2024
Recent changes for Clinical Policies
General Information
Governance Policies
CPAG Bulletins
CPAG Bulletin May 2024
Clinical Policies
Dupuytren's Contracture
Not routinely commissioned
Botulinum Toxin - When Used to Improve Cosmetic Appearance
Derby and Derbyshire ICB
